Stay updated on Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.

Latest updates to the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page now shows a revision update from v3.6.0 to v3.6.2. This appears to be a minor maintenance/update to the site behind the page and does not alter the study details or public content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNew navigation and guidance items were added, including 'No longer looking for participants', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', along with a new Intervention/Treatment section; the old 'Intervention / Treatment' heading was removed. The page revision label was updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check27 days agoChange DetectedThe page now shows revision v3.5.5, replacing v3.5.4, indicating a new site update. This metadata change does not alter study data, eligibility criteria, or any content on the page.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision label on the page has been updated from v3.5.3 to v3.5.4. This reflects a new page revision without changes to the study content or layout.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page’s “Revision” identifier was updated from v3.5.2 to v3.5.3. This reflects a platform/version update without changing the study record content shown.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This is a system-level version update and does not alter study content.SummaryDifference0.0%

Stay in the know with updates to Olaparib in gBRCA Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in gBRCA Pancreatic Cancer Clinical Trial page.